Preoperative serum caveolin-1 as a prognostic marker for recurrence in a radical prostatectomy cohort

Clinical Cancer Research

Volumn 12, Issue 16, 2006, Pages 4872-4875

  Tahir, Salahaldin A ^a   Frolov, Anna ^a   Hayes, Teresa G ^a   Mims, Martha P ^a   Miles, Brian J ^a   Lerner, Seth P ^a   Wheeler, Thomas M ^a   Ayala, Gustavo ^a   Thompson, Timothy C ^a   Kadmon, Dov ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CAVEOLIN 1; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CONTROLLED STUDY; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; STATISTICAL ANALYSIS;

ADULT; AGED; CAVEOLIN 1; COHORT STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33748342150     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-06-0417     Document Type: Article

References (13)

1. Cooperberg MR, Moul JW, Carroll PR. The changing face of prostate cancer. J Clin Oncol 2005;23:8146-51.
2. Shipley WU, Thames HD, Sandler HM, et al. Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis. JAMA 1999;281:1598-604.
3. Bracarda S, de Cobelli O, Greco C, et al. Cancer of the prostate. Crit Rev Oncol Hematol 2005;56:379-96.
4. Chin JL, Reiter RE. Molecular markers and prostate cancer prognosis. Clin Prostate Cancer 2004;3:157-64.
5. Shaul PW, Anderson RG. Role of plasmalemmal caveolae in signal transduction. Am J Physiol 1998;275:L843-51.
6. Ikonen E, Parton RG. Caveolins and cellular cholesterol balance. Traffic 2000;1:212-7.
7. Nasu Y, Timme TL, Yang G, et al. Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells. Nat Med 1998;4:1062-4.
8. Yang G, Truong LD, Wheeler TM, Thompson TC. Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic marker. Cancer Res 1999;59:5719-23.
9. 0 prostate carcinoma diagnosed in Japanese patients. Cancer 2003;97:1225-33.
10. Yang G, Addai J, Ittmann M, Wheeler TM, Thompson TC. Elevated caveolin-1 levels in African-American versus White-American prostate cancer. Clin Cancer Res 2000;6:3430-3.
11. Tahir SA, Yang G, Ebara S, et al. Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer. Cancer Res 2001;61:3882-5.
12. Tahir SA, Ren C, Timme TL, et al. Development of an immunoassay for serum caveolin-1: a novel biomarker for prostate cancer. Clin Cancer Res 2003;9:3653-9.
13. Mazumdar M, Glassman JR. Categorizing a prognostic variable: review of methods, code for easy implementation and applications to decision-making about cancer treatments. Stat Med 2000;19:113-32.